Ogata N - Search Results

1

Cumulative risk of developing a new symptom in patients with primary biliary cholangitis and its impact on prognosis.

Kimura N, Setsu T, Arao Y, Sakai N, Watanabe Y, Abe H, Kamimura H, Sakamaki A, Yokoo T, Kamimura K, Tsuchiya A, Osaki A, Igarashi K, Waguri N, Yanagi M, Takahashi T, Sugitani S, Kobayashi Y, Takamura M, Yoshikawa A, Ishikawa T, Yoshida T, Watanabe T, Bannai H, Kubota T, Funakoshi K, Wakabayashi H, Kurita S, Ogata N, Watanabe M, Mita Y, Mori S, Sugiyama M, Miyajima T, Takahashi S, Sato S, Ishizuka K, Ohta H, Aoyagi Y, Terai S. Kimura N, et al. Among authors: ogata n. JGH Open. 2022 Jul 15;6(8):577-586. doi: 10.1002/jgh3.12789. eCollection 2022 Aug. JGH Open. 2022. PMID: 35928695 Free PMC article.

2

Changes in disease characteristics of primary biliary cholangitis: An observational retrospective study from 1982 to 2016.

Takamura M, Matsuda Y, Kimura N, Takatsuna M, Setsu T, Tsuchiya A, Osaki A, Waguri N, Yanagi M, Takahashi T, Sugitani S, Kobayashi Y, Yoshikawa A, Ishikawa T, Yoshida T, Watanabe T, Bannai H, Kubota T, Funakoshi K, Wakabayashi H, Kurita S, Ogata N, Watanabe M, Mita Y, Mori S, Sugiyama M, Miyajima T, Takahashi S, Sato S, Ishizuka K, Ohta H, Aoyagi Y, Terai S; Niigata PBC Study Group. Takamura M, et al. Among authors: ogata n. Hepatol Res. 2021 Feb;51(2):166-175. doi: 10.1111/hepr.13586. Epub 2020 Nov 28. Hepatol Res. 2021. PMID: 33126288

3

Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C.

Tamura Y, Yamagiwa S, Aoki Y, Kurita S, Suda T, Ohkoshi S, Nomoto M, Aoyagi Y; Niigata Liver Disease Study Group. Tamura Y, et al. Dig Dis Sci. 2009 Nov;54(11):2530-7. doi: 10.1007/s10620-008-0642-y. Epub 2008 Dec 18. Dig Dis Sci. 2009. PMID: 19093203

4

Bleeding from a Small-Intestinal Ulcer Associated with Chronic Hepatitis C.

Kamimura H, Yamagiwa S, Tomohiro I, Higuchi W, Ogata N, Tsuchiya A, Kamimura K, Takamura M, Kawai H, Terai S. Kamimura H, et al. Among authors: ogata n. Am J Case Rep. 2018 Mar 3;19:234-237. doi: 10.12659/ajcr.908594. Am J Case Rep. 2018. PMID: 29500336 Free PMC article.

5

[Indications and efficacy of hepatitis B vaccines (HB vaccines) and hepatitis B immune globulin (HBIG): current situations and problems of hepatitis B virus (HBV) infection-preventing strategies in Japan].

Ogata N, Funada H, Aoyagi Y. Ogata N, et al. Nihon Rinsho. 2011 May;69 Suppl 4:408-16. Nihon Rinsho. 2011. PMID: 22096953 Japanese. No abstract available.

6

Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients.

Kuwana K, Ichida T, Kamimura T, Ohkoshi S, Ogata N, Harada T, Endoh K, Asakura H. Kuwana K, et al. Among authors: ogata n. J Gastroenterol Hepatol. 1997 Feb;12(2):149-55. doi: 10.1111/j.1440-1746.1997.tb00398.x. J Gastroenterol Hepatol. 1997. PMID: 9083916

7

Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity.

Ogata N, Ichida T, Aoyagi Y, Kitajima I. Ogata N, et al. Rinsho Byori. 2003 Apr;51(4):313-9. Rinsho Byori. 2003. PMID: 12747252

8

Remote development of hepatocellular carcinoma in patients with liver cirrhosis type B serologically cured for HBs antigenemia with long-standing normalization of ALT values.

Okoshi S, Igarashi M, Suda T, Iwamatsu H, Watanabe K, Ishihara K, Ogata N, Nomoto M, Takahashi T, Ichida T, Asakura H, Nihei K, Kurosaki I. Okoshi S, et al. Among authors: ogata n. Dig Dis Sci. 2002 Sep;47(9):2002-6. doi: 10.1023/a:1019608509402. Dig Dis Sci. 2002. PMID: 12353845

9

[A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin for chronic hepatitis C].

Watanabe T, Inoue M, Harada K, Homma N, Uchida M, Ogata N, Funada R, Hasegawa K, Soga K, Shibasaki K. Watanabe T, et al. Among authors: ogata n. Nihon Shokakibyo Gakkai Zasshi. 2006 Sep;103(9):1061-6. Nihon Shokakibyo Gakkai Zasshi. 2006. PMID: 16953104 Japanese.

10

[Comparison of antibody responses to hepatitis B surface antigen among four recipient groups of hepatitis B vaccines that have been approved in Japan: evaluation using passive hemagglutination assay and chemiluminescent immunoassay].

Ogata N. Ogata N. Rinsho Byori. 2009 Oct;57(10):954-60. Rinsho Byori. 2009. PMID: 19928491 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

670 results

Search Page